5 ml of syrup contain: Triprolidine hydrochloride 1.25 mg, Pseudoephedrine hydrochloride 30 mg, Dextromethorphan hydrobromide 10 mg
Symptomatic treatment of the upper respiratory tract inflammations (flu, colds and other upper respiratory tract infections) with cough, nasal congestion and watery nasal discharge.
Hypersensitivity to any component of the product.
Concomitant treatment with monoamine oxidase inhibitors (MAOIs), or within 2 weeks after discontinuation of MAO inhibitors.
Severe liver and kidney failure or damage.
Respiratory failure or the risk of its occurrence.
Cough with plenty of secretions and cough associated with bronchial asthma.
Severe coronary heart disease.
The product should not be used in pregnant and breastfeeding women and children up to 7 years.